12 weeks of a ribavirin-free sofosbuvir and nonstructural protein 5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Houssel-Debry P, Coilly A, Fougerou-Leurent C, et al. 12 weeks of a ribavirin-free sofosbuvir and nonstructural protein 5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation. Hepatology. 2018;68(4):1277-1287.

Publication Type:

Journal Article

Authors:

Houssel-Debry, P; Coilly, A; Fougerou-Leurent, C; et, al

Source:

Hepatology, Volume 68, Issue 4, p.1277-1287 (2018)

Cited On:

Export Citation:
RIS Format
Top